Haplotype Analysis of BRCA1 Gene D17S855 and D17S1322 Markers in Iranian Familial Breast Cancer Patients |
Miresmaeili, Sayed Mohsen
(Department of Biology, Science Faculty, University of Sistan and Baluchestan)
Tamandani, Dor Mohammad Kordi (Department of Biology, Science Faculty, University of Sistan and Baluchestan) Kalantar, Seyed Mehdi (Research and Clinical Center for Infertility, Shahid Sadoughi University of Medical Sciences) Moshtaghiun, Seyed Mohammad (University of Yazd) |
1 | Alsop K, Fereday S, Meldrum C, et al (2012). BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: A report from the Australian ovarian cancer study group. J Clin Oncol, 30, 2654-63. DOI |
2 | Clark SL, Rodriguez AM, Snyder RR, (2012). Structure-Function Of The Tumor Suppressor BRCA1. Comput Struct Biotechnol J. Research Network Computational Structural Biotechnol, 1, 1-8. |
3 | De La Hoya M, Sulleiro S, Osorio A, et al (2002). Clustering of cancer-related mutations in a subset of BRCA1 alleles: A study in the Spanish population. Int J Cancer, 100, 618-9. DOI |
4 | Haiman CA, Stram DO, Pike MC, et al (2003). A comprehensive haplotype analysis of CYP19 and breast cancer risk: the Multiethnic Cohort. Hum Mol Genet, 12, 2679-92. DOI |
5 | Forat-Yazdi M, Neamatzadeh H, Sheikhha MH, et al (2015). BRCA1 and BRCA2 common mutations in Iranian breast cancer patients: a meta-analysis. Asian Pac J Cancer Prev, 16, 1219-24. DOI |
6 | Friedenson B (2005). BRCA1 and BRCA2 Pathways and the risk of cancers other than breast or ovarian. Med Gen Med, 7, 60. |
7 | Laitman Y, Feng B-J, Zamir IM, et al (2012) Haplotype analysis of the 185delAG BRCA1 mutation in ethnically diverse populations. Eur J Hum Genet. Nature Publishing Group, 21, 212-6. |
8 | Mefford HC, Baumbach L, Panguluri RC, et al (1999) Evidence for a BRCA1 founder mutation in families of West African ancestry. Am J Hum Genet, 65, 575-8. DOI |
9 | Miresmaeili M, Kordi D M, Kalantar M, Moshtaghioun M (2016) Haplotype analysis of BRCA1 intragenic markers in Iranian patients with familial breast and ovarian cancer. Int J Reprod BioMed, 14, 271-4 DOI |
10 | Neamatzadeh H, Shiryazdi SM, Kalantar SM (2015). BRCA1 and BRCA2 mutations in Iranian breast cancer patients: A systematic review. J Res Med Sci, 20, 284-93. |
11 | Walsh T, Casadei S, Coats KH, et al (2006). Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer. JAMA, 295, 1379-88. DOI |
12 | Nowacka-Zawisza M, Brys M, Romanowicz-Makowska H, et al (2008). Dinucleotide repeat polymorphisms of RAD51, BRCA1, BRCA2 gene regions in breast cancer: Original Article. Pathol Int, 58, 275-81. DOI |
13 | Osorio A, de la Hoya M, Rodriguez-Lopez R, et al (2003). Over-representation of two specific haplotypes among chromosomes harbouring BRCA1 mutations. Eur J Hum Genet, 11, 489-92. DOI |
14 | Ticha I, Kleibl Z, Stribrna J, et al (2012). Screening for genomic rearrangements in BRCA1 and BRCA2 genes in Czech high-risk breast/ovarian cancer patients: high proportion of population specific alterations in BRCA1 gene. Breast Cancer Res Treat, 124, 337-47. |